drugset / Trial / NCT01854749

S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study

NCT01854749 ↗

Phase 2 Completed 57 enrolled Fudan University
NaSingle-groupOpen-labelTreatment

Summary

Assess the efficacy and safety of S1 combined with cisplatin in treatment of recurrence/metastasis of ESCC

Timeline

Start
2011-11
Primary completion
2015-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified — —
Subject S-1 Small molecule — —